Berkshire Hathaway ups drug-stock stakes while trimming Apple

Warren Buffett’s Berkshire Hathaway Inc.
BRK.A,
+1.19%

BRK.B,
+1.16%
loaded up on drug, telecom and oil stocks while trimming its position in Apple Inc.
AAPL,
-1.61%
over the past quarter, according to a Securities and Exchange Commission filing late Tuesday. Berkshire increased its stake in Abbvie Inc.
ABBV,
-0.23%
by 20%, Bristol-Myers Squibb Co.
BMY,
-0.98%
by 11%, and Merck & Co.
MRK,
-1.00%
by 28%. Notably, Berkshire trimmed it stake in Apple by 6% to just over 887 million shares. Other big moves by Berkshire included more than doubling its stake in T-Mobile US Inc.
TMUS,
-1.36%
to 5.2 million shares and a new 146.7 million share stake in Verizon Communications Inc.
VZ,
-0.09%,
a new 48.5 million stake in Chevron Corp.
CVX,
+2.05%,
a 34% hike in its Kroger Co.
KR,
-0.85%
stake, a 59% cut in its Wells Fargo & Co.
WFC,
+3.76%
stake, and a 28% cut in its Suncor Energy Inc.
SU,
+4.22%
stake.